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Abstract: 
Background: The Alzheimer’s disease (AD) is a devastating neurodegenerative 
disorder and the most common cause of dementia. The pathological hallmarks of 
AD are the presence of neurofibrillary tangles and amyloid deposits in the brain of 
the patient, as already defined by Alois Alzheimer in 1907. The aim of our study is 
to inhibit the formation the folding of amyloid protein by new synthesis of -sheet 
breaker peptides. 
Methods: Our approach consist to develop -sheet breaker peptides as a novel 
strategy to inhibit and reverse amyloidosis in AD. The synthesis was down by 
peptid coupling method. 
Results: Several -sheet breaker peptides have been designed based on the 
hypothesis that amyloid deposition could be inhibited by short synthetic peptides 
partially homologous to the A region undergoing conformational changes to give 
rise to the amyloidogenic A intermediate and containing residues disrupting as 
aziridine and CD for the -sheet formation university Tlemcen 2017.. 
Conclusion: At present, there is no ideal drug for the treatment of AD, and the 
searches for AD drugs remain an urgent issue in the pharmaceutical community. 
Due to its complex pathogenesis, a single target drug cannot cure this disease 
fundamentally. Dual or multiple target drugs involved in two or more aspects of 
AD pathogenesis may generate a synergistic effect and ultimately achieve an ideal 
therapeutic effect. 
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